Alpha7 nAChR Agonists for Cognitive Deficit and Negative Symptoms in Schizophrenia: A Meta-analysis of Randomized Double-blind Controlled Trials

BACKGROUND: Previous clinical trials of α7-nicotinic acetylcholine receptor agonists (α7-nAChR agonists) showed mixed results in treating the cognitive and negative symptoms of schizophrenia. AIMS: To assess the efficacy and safety of α7-nAChR agonists in treating the cognitive and negative symptoms...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shanghai Municipal Bureau of Publishing 2017
Materias:
Systematic Review and Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608991/
https://www.ncbi.nlm.nih.gov/pubmed/28955138
http://dx.doi.org/10.11919/j.issn.1002-0829.217044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608991/
https://www.ncbi.nlm.nih.gov/pubmed/28955138
http://dx.doi.org/10.11919/j.issn.1002-0829.217044

Ejemplares similares